Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Cash flows from operating activities
Net income	$ 1,545	$ 1,179
Adjustments to net income:
Depreciation	541	424
Amortization of capitalized software	21	20
Stock compensation	109	116
Gains on sales of assets	(5)	0
Deferred taxes	(4)	(87)
Increase (decrease) from changes in:
Accounts receivable	(282)	(141)
Inventories	109	(160)
Prepaid expenses and other current assets	(9)	(7)
Accounts payable and accrued expenses	(125)	(121)
Accrued compensation	(447)	(427)
Income taxes payable	130	132
Changes in funded status of retirement plans	4	(9)
Other	(67)	(70)
Cash flows from operating activities	1,520	849
Cash flows from investing activities
Capital expenditures	(676)	(1,123)
Proceeds from U.S. CHIPS and Science Act (CHIPS Act) incentives	555	260
Proceeds from asset sales	5	0
Purchases of short-term investments	(935)	(647)
Proceeds from short-term investments	1,043	2,807
Other	(39)	(44)
Cash flows from investing activities	(47)	1,253
Cash flows from financing activities
Repayment of debt	0	(750)
Dividends paid	(1,291)	(1,238)
Stock repurchases	(158)	(653)
Proceeds from common stock transactions	309	118
Other	(9)	(16)
Cash flows from financing activities	(1,149)	(2,539)
Net change in cash and cash equivalents	324	(437)
Cash and cash equivalents at beginning of period	3,225	3,200
Cash and cash equivalents at end of period	3,549	2,763
Supplemental cash flow information
Investment tax credit (ITC) used to reduce income taxes payable	0	0
Proceeds from CHIPS Act incentives	555	260
Total cash benefit related to the CHIPS Act	$ 555	$ 260